XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders’ Equity (Tables)
6 Months Ended
Nov. 30, 2025
Equity [Abstract]  
Schedule of share based compensation stock options activity
                    
   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Term   Intrinsic Value (1) 
Outstanding as of May 31, 2025   902,750   $3.48    8.7   $1,382,078 
Granted   -    -           
Exercised/Forfeited   -    -           
Outstanding as of November 30, 2025   902,750    3.48    8.2    1,547,140 
Exercisable at November 30, 2025   475,250   $2.99    7.5   $1,079,430 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period.